Lisdexamfetamine: new secondline treatment option in ADHD

Lisdexamfetamine is a prodrug of dexamfetamine indicated for the treatment of ADHD. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Dr David Hayward discusses its place in treatment compared with methylphenidate.

Lisdexamfetamine new second line treatment option in ADHD

Add yours ↓
Web design and marketing agency Leamington Spa